Sector: MedicalADVANCE MAGNETIC (NASDAQ: AMAG)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 1 |
Technical : | 7 |
Performance : | 9 |
Overall: | 1 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 1 |
Technical : | 44 |
Performance : | 13 |
Overall: | 1 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 1 |
Technical : | 126 |
Performance : | 42 |
Overall: | 8 |
Number of Stocks: | 306 |
Headlines
- AMAG Pharmaceuticals, Inc. to Participate in the Lazard Capital Markets 6th Annual Healthcare Conference
Nov 12, 2009 04:15 PM | AMAG
- AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Quarter Ended September 30, 2009
Oct 21, 2009 08:30 AM | AMAG
- AMAG Pharmaceuticals, Inc. Announces Data Presentations at the American Society of Nephrology (ASN) Renal Week Meeting
Oct 07, 2009 09:05 AM | AMAG
- AMAG Pharmaceuticals, Inc. to Provide Company Update at the Morgan Stanley Global Healthcare Unplugged Conference
Sep 10, 2009 04:05 PM | AMAG, MS
- AMAG Pharmaceuticals Adopts Shareholder Rights Plan
Sep 04, 2009 04:05 PM | AMAG
- AMAG Pharmaceuticals, Inc. to Present at the Baird 2009 Healthcare Conference
Sep 02, 2009 04:05 PM | AMAG
- Rockwell Medical (NASDAQ:RMTI): Early-Stage AMAG Growth Potential
Sep 02, 2009 12:48 PM | AMAG, RMTI
- Post Market Report: Wall Street Gains On Economic Optimism, Kraft Foods (NYSE: KFT) Jumps
Jul 01, 2009 07:07 PM | AMAG, F, GIS, INTC, KFT, KO
- US Stocks Poised To Open Higher, Economic Data In Spotlight
Jul 01, 2009 09:00 AM | AMAG, C, GIS, OSK, STZ, ZZ
- FDA Calendar Updates: Feraheme Approval For AMAG
Jun 30, 2009 09:57 PM | AMAG
- Analyst Choice Brings New Analysis on Level 3 Communications Inc., Arris Group Inc., Virgin Media Inc., The South Financial Group Inc., Wynn Resorts Limited and AMAG Pharmaceuticals Inc.
Nov 20, 2009 10:18 AM | AMAG, ARRS, LVLT, TSFG, VMED, WYNN
- AMAG Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2009
Oct 29, 2009 07:51 AM | AMAG
- AMAG Pharmaceuticals, Inc. to Present at the Canaccord Adams 29th Annual Global Growth Conference
Aug 04, 2009 04:12 PM | AMAG
- AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended June 30, 2009
Jul 29, 2009 04:11 PM | AMAG
- AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2009
Jul 22, 2009 05:21 PM | AMAG
- AMAG Pharmaceuticals Announces U.S. Launch of Feraheme™ (ferumoxytol) Injection
Jul 13, 2009 04:34 PM | AMAG
- FDA Approves Feraheme™ to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
Jun 30, 2009 04:45 PM | AMAG
- FDA Decision on Feraheme NDA Expected Within Next Few Days
Jun 29, 2009 06:51 PM | AMAG
- AMAG Pharmaceuticals, Inc. to Present at the Jefferies Third Annual Healthcare Conference
Jun 12, 2009 09:08 AM | AMAG
- AMAG Pharmaceuticals Announces Appointment of Ricardo Zayas as Senior Vice President of Operations
Jun 08, 2009 04:08 PM | AMAG
- Form 4 AMAG PHARMACEUTICALS For: Nov 12 Filed by: ADAGE CAPITAL PARTNERS LP (10K)
Nov 16, 2009 02:55 PM
- Form 4 AMAG PHARMACEUTICALS For: Jun 02 Filed by: ALLEN LEE F MD PhD (10K)
Nov 13, 2009 04:43 PM
- Form 4 AMAG PHARMACEUTICALS For: Nov 09 Filed by: Pereira Brian JG (10K)
Nov 12, 2009 05:07 PM
- Form 4 ADAGE CAPITAL PARTNERS For: Nov 06 (10K)
Nov 10, 2009 07:39 PM
- Form 4 ADAGE CAPITAL PARTNERS For: Nov 03 (10K)
Nov 05, 2009 08:48 PM
- Form 4 NARACHI MICHAEL For: Oct 06 (10K)
Oct 08, 2009 06:13 PM
- Form 4 ALLEN LEE F MD PhD For: Aug 06 (10K)
Aug 06, 2009 05:42 PM
- Form 4 Pereira Brian JG For: Aug 03 (10K)
Aug 05, 2009 05:48 PM
- Form 4 Healey Timothy G For: Aug 03 (10K)
Aug 03, 2009 06:02 PM
- Form 4 Zayas Ricardo For: Jun 08 (10K)
Jun 09, 2009 11:51 AM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
AMAG
|
Compare to S&P
|
| YTD |
10.88 %
|
-8.23 %
|
| 4 Weeks |
10.42 %
|
9.22 %
|
| 12 Weeks |
-3.92 %
|
-9.41 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 16.77 %
|
|
EPS Growth in Last Year: 7.19 %
|
|
Sales Growth in Last Quarter: 5,392.73 %
|
|
Sales Growth in Last Quarter: 1,061.92 %
|
|
